BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu H, Klein RS, Schwartz EL. Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap. Clin Cancer Res 2009;15:5136-44. [PMID: 19671868 DOI: 10.1158/1078-0432.CCR-08-3203] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Wu G, Shi X, Lian Y, Xiang H, Xiong J. Crystal structure of N,N-diethyl-5-bromo-3,4-dihydro-2,4-dioxopyrimidine-1(2H)-carboxamide, C9H12BrN3O3. Zeitschrift für Kristallographie - New Crystal Structures 2017;232:99-100. [DOI: 10.1515/ncrs-2016-0169] [Reference Citation Analysis]
2 Lee JG, Wu R. Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo. Neoplasia. 2015;17:190-200. [PMID: 25748238 DOI: 10.1016/j.neo.2014.12.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
3 Wei Q, Liu H, Zhou H, Zhang D, Zhang Z, Zhou Q. Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways. BMC Cancer 2015;15:159. [PMID: 25881156 DOI: 10.1186/s12885-015-1149-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu W, Feng X, Tao Y, Zhou Z, Wu G, Xiong J. Synthesis and Structural Studies of Three Uracil Derivatives, Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanate, Methyl 3-(5-Nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate and Ethyl 3-(5-Nitro-2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl)propanoate. J Chem Crystallogr 2014;44:597-603. [DOI: 10.1007/s10870-014-0554-y] [Reference Citation Analysis]
5 Tertil M, Skrzypek K, Florczyk U, Weglarczyk K, Was H, Collet G, Guichard A, Gil T, Kuzdzal J, Jozkowicz A, Kieda C, Pichon C, Dulak J. Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1. PLoS One 2014;9:e97070. [PMID: 24819505 DOI: 10.1371/journal.pone.0097070] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang B, Li Q, Qin L, Zhao S, Wang J, Chen X. Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC Immunol 2011;12:43. [PMID: 21813021 DOI: 10.1186/1471-2172-12-43] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 7.3] [Reference Citation Analysis]
7 Stark M, Bram EE, Akerman M, Mandel-Gutfreund Y, Assaraf YG. Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance. J Biol Chem. 2011;286:3741-3754. [PMID: 21068389 DOI: 10.1074/jbc.m110.163444] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]